What is the recommended dosing frequency for a 120mg dose of fexofenadine (Allegra)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fexofenadine 120mg Dosing Recommendation

Fexofenadine 120mg should be administered once daily for adults and children ≥12 years with seasonal allergic rhinitis or chronic idiopathic urticaria. 1

Dosing Frequency

  • The 120mg dose is taken once daily in the morning 2, 3, 4
  • This once-daily regimen provides 24-hour symptom control with efficacy maintained throughout the entire dosing interval 3
  • An alternative dosing strategy of 60mg twice daily (total 120mg/day) is equally effective but once-daily dosing improves patient compliance 4, 5

Administration Guidelines

  • Take with water only - avoid fruit juices (grapefruit, orange, apple) which reduce bioavailability by 36% and diminish therapeutic effects 2
  • Separate from antacids - aluminum and magnesium-containing antacids decrease fexofenadine absorption by 41% (AUC) and 43% (Cmax) when taken within 15 minutes 2
  • Timing: Administer at 8 AM for optimal symptom control throughout the day 4

Efficacy Evidence

  • The 120mg once-daily dose demonstrates equivalent efficacy to cetirizine 10mg once daily for seasonal allergic rhinitis 3
  • Both 120mg and 180mg once-daily doses show superior efficacy compared to placebo (p ≤ 0.05) with no significant difference between these two doses 4
  • For chronic idiopathic urticaria, doses of 60mg twice daily (equivalent to 120mg total daily) or greater provide optimal symptom reduction 6

Safety Profile

  • Adverse events occur at placebo-equivalent rates - the safety profile is similar to placebo even at doses up to 240mg/day 1, 5
  • Headache is the most common adverse event (8.9% vs 7.5% placebo) 4
  • No sedation occurs at the 120mg dose, distinguishing it from cetirizine which causes drowsiness in 9% of patients 3, 5
  • No cardiac effects or QTc prolongation, even when combined with erythromycin or ketoconazole 2

Special Populations

  • No dose adjustment needed in elderly patients (≥65 years) based on age alone 1
  • Reduced doses recommended in renal impairment, though the medication remains well-tolerated 1

References

Guideline

Fexofenadine Dosage and Safety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The systemic safety of fexofenadine HCl.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.